Attached files
file | filename |
---|---|
EX-99.01 - Inspyr Therapeutics, Inc. | v167883_ex99-01.htm |
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of
1934
Date of report (Date of earliest event
reported): November 30, 2009
GENSPERA, INC.
(Exact name of registrant as specified
in Charter)
Delaware
|
0001421204
|
20-0438951
|
||
(State or other jurisdiction
of
incorporation or
organization)
|
(Commission File
No.)
|
(IRS Employee Identification
No.)
|
||
9901
IH 10 West, Suite 800
San
Antonio, TX 78230
|
||||
(Address of Principal Executive
Offices)
|
||||
210-477-8537
|
||||
(Issuer Telephone
number)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction
A.2. below):
o
|
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 7.01.
|
Regulation FD
Disclosure.
|
On
November 30, 2009, GenSpera, Inc. (“Company”) released an Executive
Informational Overview dated November 23, 2009 (“EIO”). The EIO was
prepared by the Company with the assistance of Crystal Research Associates, LLC
in continuation of the Company’s stated goal to provide more disclosure and
transparency to the investment community regarding its operations, goals,
industry dynamics and conditions. A copy of EIO is attached hereto as
Exhibits 99.01
The
information contained in this Current Report on Form 8-K and the exhibits
attached hereto shall not be deemed to be “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liabilities of that section, nor shall such information
or such exhibits be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The information set
forth herein and in the exhibits to this Form 8-K shall not be deemed an
admission as to the materiality of any information provided and is being made
solely to satisfy the requirements of Regulation FD.
Item
9.01
|
Financial Statement and
Exhibits.
|
The
exhibits listed in the accompanying index to exhibits are filed or incorporated
by reference.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
GenSpera,
Inc.
|
||
By:
|
/s/
Craig Dionne
|
|
Craig
Dionne
Chief Executive
Officer
|
Dated: November 30,
2009
INDEX
OF EXHIBITS
|
|
|
Incorporated
by Reference
|
||||||||||
Exhibit
No.
|
Description
|
Filed
Herewith
|
Form
|
Exhibit
No.
|
File No.
|
Filing Date
|
||||||
99.01
|
Executive
Informational Overview dated November 23, 2009
|
*
|